Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patient

Rheumatology (Oxford). 2011 Apr;50(4):808-10. doi: 10.1093/rheumatology/keq417. Epub 2010 Dec 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use*
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Crohn Disease / complications
  • Drug Therapy, Combination
  • Eye / pathology
  • Humans
  • Infliximab
  • Lymphoma, Non-Hodgkin / chemically induced*
  • Lymphoma, Non-Hodgkin / etiology
  • Lymphoma, Non-Hodgkin / pathology
  • Magnetic Resonance Imaging
  • Male
  • Methotrexate / adverse effects*
  • Methotrexate / therapeutic use*
  • Middle Aged
  • Risk Factors
  • Treatment Outcome
  • Withholding Treatment*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Infliximab
  • Methotrexate